integrarray_qc_guidelines
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| integrarray_qc_guidelines [2025/12/23 16:13] – [Molecular validation of findings.] 206.192.168.19 | integrarray_qc_guidelines [2026/01/23 21:20] (current) – Added Files 206.192.168.19 | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| ==== 1. Genotype Calling ==== | ==== 1. Genotype Calling ==== | ||
| - | Genotypes were called for many samples at the Center for Inherited Disease Research (CIDR). The genotyping platform used was the Global Screening Plus Custom Array (here called the GSA array but also referenced as product by BPM Amos_Custom_20032937X382854_A1, | + | Genotypes were called for many samples at the Center for Inherited Disease Research (CIDR). The genotyping platform used was the Global Screening Plus Custom Array (here called the GSA array but also referenced as product by BPM Amos_Custom_20032937X382854_A1, |
| ===== 2. Sample QC ===== | ===== 2. Sample QC ===== | ||
| Line 182: | Line 182: | ||
| - | No samples were dropped; all samples will be included in the imputation, the marker lists of all steps can be found in file: {{ :duplicates-report-reformattedgood.xlsx |}} | + | No samples were dropped; all samples will be included in the imputation, the marker lists of all steps can be found in file: {{ :integrarray_qc_guidelines_marker_list.xlsx |}} |
| * **735,370** markers in the original release (chr1–chr23) | * **735,370** markers in the original release (chr1–chr23) | ||
integrarray_qc_guidelines.1766506421.txt.gz · Last modified: by 206.192.168.19